Abalone Bio

Developer of antibody drugs for pain management and cancer

placeRichmond, California, United States calendar_todayFounded 2017 groups20 employees language abalonebio.com

Innovation

3 patent families (1 granted) — focus: Physics & computing, Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 295 times.

YearFilings
20191
20201
20211
20231
20241
20253

Social engagement

Social engagement: 3.9K social following, 5 posts in the last 12 months — above the industry median.

Investor mix

8 investors on record; lead investors include Y Combinator.

Investor typeCountShare
Venture capital675%
Other / undisclosed225%

Recent activity

15 Apr 2026
Event
Antibody & ADC Summit
10 Mar 2026
Milestone
regulatory
Coming soon